Skip to main content
. 2022 Aug 19;27(11):103336. doi: 10.1016/j.drudis.2022.08.004

Figure 2.

Figure 2

Viral vector vaccines are created using recombinant DNA techniques and involve the use of an attenuated adenovirus that carries the genetic code for the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) spike (S) protein.